| Net income (loss) | -20.11M |
| Depreciation | 10.15M |
| Amortization of intangible assets | 3.77M |
| Provision for doubtful accounts | 335K |
| Impairment of auction rate securities | |
| Stock-based compensation and charges | 10.16M |
| Earnings of unconsolidated joint venture | -2.71M |
| Other non-cash items | -46K |
| Accounts receivable | -229K |
| Other assets | -1.16M |
| Accounts payable and accrued expenses | 8.21M |
| Deferred revenue | -706K |
| Net cash provided by operating activities | |
| Purchases of property and equipment | -15.1M |
| Proceeds from the sale of auction rate securities | |
| Proceeds from the sale of marketable equity securities | |
| Distribution of earnings from unconsolidated joint venture | |
| Net cash (used in) provided by investing activities | |
| Proceeds from exercise of stock options | 7.45M |
| Redemption of convertible preferred stock | |
| Payment of dividend on convertible preferred stock | |
| Tax payment related to net share settlements of restricted stock awards | -2.25M |
| Proceeds from line of credit | |
| Principal payments on line of credit | |
| Restricted cash | |
| Proceeds from loan payable | |
| Principal payments on loan payable | 0 |
| Net cash used in financing activities | |
| Change in cash and cash equivalents | |
| Cash and cash equivalents, beginning of period | 118.68M |
| Cash and cash equivalents, end of period | 115.19M |